Cephalon Limited

1 Albany Place, Hyde Way, Welwyn Garden City, Hertfordshire, AL7 3BT, UK
Telephone: +44 (0)1707 385800
Fax: +44 (0)1707 385801
WWW: http://www.cephalon.co.uk
Medical Information Direct Line: 0800 783 4869
Medical Information e-mail: ukmedinfo@cephalon.com
Summary of Product Characteristics last updated on the eMC: 10/03/2008
SPC Abelcet

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/03/2008 and displayed until Current
Reasons for adding or updating:
  • Change to MA holder contact details
Date of revision of text on the SPC:   11/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 7: MAH contact address changed from The Magdalen centre, Oxford science park, Oxford, OX4 4GA, UK to 1 Albany Place, Hyde way, Welwyn Garden City, Hertfordshire, AL7 3BT

Updated on 12/06/2007 and displayed until 10/03/2008
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Date of revision of text on the SPC:   11/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 7 - Marketing Authorisation Holder changed from:
 
Zeneus Pharma Ltd

The Magdalen Centre

Oxford Science Park

Oxford

OX4 4GA

United Kingdom

 

to:

 

Cephalon Limited

The Magdalen Centre

Oxford Science Park

Oxford

OX4 4GA

United Kingdom
Updated on 13/03/2006 and displayed until 12/06/2007
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
  • Change to section 5.1 - Pharmacodynamic Properties
  • Change to section 6.1 - List of Excipients
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 6. 6 - Instruction for Use/Handling
  • Change to section 9 - Date of Renewal of Authorisation
  • Change to section 10 (date of (partial) revision of the text
Updated on 28/09/2005 and displayed until 13/03/2006
Reasons for adding or updating:
  • Change to section 8 - MA number
  • Change to section 7 - Marketing Authorisation Holder
Updated on 28/05/2004 and displayed until 28/09/2005
Reasons for adding or updating:
  • Company name change or merger
Updated on 08/07/2003 and displayed until 28/05/2004
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
Updated on 09/01/2002 and displayed until 08/07/2003
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MA number
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 05/07/2001 and displayed until 09/01/2002
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 03/04/2001 and displayed until 05/07/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 17/11/2000 and displayed until 03/04/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 17/11/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   amphotericin


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk